White D - Search Results

1

Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival.

Neilson JR, Auer R, White D, Bienz N, Waters JJ, Whittaker JA, Milligan DW, Fegan CD. Neilson JR, et al. Among authors: white d. Leukemia. 1997 Nov;11(11):1929-32. doi: 10.1038/sj.leu.2400819. Leukemia. 1997. PMID: 9369428

2

Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease.

Fegan C, Robinson H, Thompson P, Whittaker JA, White D. Fegan C, et al. Among authors: white d. Leukemia. 1995 Dec;9(12):2003-8. Leukemia. 1995. PMID: 8609709

3

C-myc amplification, double minutes and homogenous staining regions in a case of AML.

Fegan CD, White D, Sweeney M. Fegan CD, et al. Among authors: white d. Br J Haematol. 1995 Jun;90(2):486-8. doi: 10.1111/j.1365-2141.1995.tb05183.x. Br J Haematol. 1995. PMID: 7540858

4

A novel CSF-1 binding factor in a patient in complete remission following cytotoxic therapy for lymphoma.

Baker AH, Cachia PG, Tennant GB, Whittaker JA, White D, Stanley ER, Burnett AK, Padua RA. Baker AH, et al. Among authors: white d. Br J Haematol. 1995 Jan;89(1):219-22. doi: 10.1111/j.1365-2141.1995.tb08937.x. Br J Haematol. 1995. PMID: 7833270

5

Alterations of the retinoic acid receptor alpha (RAR alpha) gene in myeloid and lymphoid malignancies.

Parrado A, West R, Jordan D, Bastard C, McKenna S, Whittaker JA, Bentley P, White D, Chomienne C, Padua RA. Parrado A, et al. Among authors: white d. Br J Haematol. 1999 Mar;104(4):738-41. doi: 10.1046/j.1365-2141.1999.01240.x. Br J Haematol. 1999. PMID: 10192433 Free article.

6

The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.

Morgan GJ, Gregory WM, Davies FE, Bell SE, Szubert AJ, Brown JM, Coy NN, Cook G, Russell NH, Rudin C, Roddie H, Drayson MT, Owen RG, Ross FM, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Studies Group. Morgan GJ, et al. Blood. 2012 Jan 5;119(1):7-15. doi: 10.1182/blood-2011-06-357038. Epub 2011 Oct 20. Blood. 2012. PMID: 22021371 Free article. Clinical Trial.

7

RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up.

Padua RA, Guinn BA, Al-Sabah AI, Smith M, Taylor C, Pettersson T, Ridge S, Carter G, White D, Oscier D, Chevret S, West R. Padua RA, et al. Among authors: white d. Leukemia. 1998 Jun;12(6):887-92. doi: 10.1038/sj.leu.2401044. Leukemia. 1998. PMID: 9639416

8

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial.

Morgan GJ, Davies FE, Gregory WM, Szubert AJ, Bell SE, Drayson MT, Owen RG, Ashcroft AJ, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Studies Group. Morgan GJ, et al. Blood. 2012 Jun 7;119(23):5374-83. doi: 10.1182/blood-2011-11-392522. Epub 2012 Apr 12. Blood. 2012. PMID: 22498739 Free article. Clinical Trial.

9

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.

Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Navarro Coy N, Cook G, Feyler S, Johnson PR, Rudin C, Drayson MT, Owen RG, Ross FM, Russell NH, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Studies Group. Morgan GJ, et al. Haematologica. 2012 Mar;97(3):442-50. doi: 10.3324/haematol.2011.043372. Epub 2011 Nov 4. Haematologica. 2012. PMID: 22058209 Free PMC article. Clinical Trial.

10

Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study.

Bahlis NJ, Dimopoulos MA, White DJ, Benboubker L, Cook G, Leiba M, Ho PJ, Kim K, Takezako N, Moreau P, Kaufman JL, Krevvata M, Chiu C, Qin X, Okonkwo L, Trivedi S, Ukropec J, Qi M, San-Miguel J. Bahlis NJ, et al. Leukemia. 2020 Jul;34(7):1875-1884. doi: 10.1038/s41375-020-0711-6. Epub 2020 Jan 30. Leukemia. 2020. PMID: 32001798 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,970 results

Search Page